Skip to main content

How Can the Latest Regulatory Advances in Endotoxin Testing Support Your Green Agenda?

    

Watch our on-demand webinar to explore the innovations shaping the future of endotoxin testing. This webinar delves into the ground-breaking developments in synthetic Bacterial Endotoxin Test (BET) methods, as well as the implications of the new USP Chapter <86> for endotoxin testing.

 

 Topics include:

 

  • The scientific, regulatory, and sustainability drivers that have heralded a new era in endotoxin testing
  • The changes introduced in USP Chapter <86>
  • The Recombinant FactorC C (rF) method, including guidelines on its implementation and validation  
  • bioMérieux’s ENDONEXT™ range, a robust line of synthetic rFC endotoxin testing solutions designed to meet the needs of various sample types

 

 

 

    

Fill out the form below to view the webinar.

Please accept targeting cookies to allow content

Continue Your Journey

ENDONEXT™ Solutions

ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.

Learn More
eBook

eBook: Your Quick Guide To Better Endotoxin Testing

Discover basic knowledge around endotoxin and endotoxin detection, and learn the best practices of tasks including method development, verification, validation and the routine testing of various drug types.

Learn More

The Future of Endotoxin Testing: USP Chapter <86> and the Shift to Recombinant Methods

For the past 50 years, the Limulus amebocyte lysate (LAL) test has served as the foundation of drug and medical device manufacturing endotoxin control. Now, however, the United States Pharmacopeia (USP) has recognized the need to transition to recombinant methods. 

Learn More